Neurol India: Table of Contents

	Open access journal indexed with Index Medicus
	Users online: 887

Home | Login

Editorial board

Article Cited by others

REVIEW ARTICLE

Dysferlinopathies

Urtizberea J Andoni, Bassez Guillaume, Leturcq France, Nguyen Karine, Krahn Martin, Levy Nicolas

Year : 2008| Volume: 56| Issue : 3 | Page no: 289-297

This article has been cited by

1	Dysferlinopathy, with mild cardiac involvement, from a novel mutation of DYSF gene

	J Y Shen, K Prasad, L L Goh, S Angkodjojo, C Y Khoo, T Umapathi

	QJM: An International Journal of Medicine. 2023;

	[Pubmed] [Google Scholar] [DOI]

2	Dysferlinopathies: Clinical and genetic variability

	Alisa Ivanova, Svetlana Smirnikhina, Alexander Lavrov

	Clinical Genetics. 2022;

	[Pubmed] [Google Scholar] [DOI]

3	The C2 domains of dysferlin: roles in membrane localization, Ca 2+ signalling and sarcolemmal repair

	Joaquin Muriel, Valeriy Lukyanenko, Tom Kwiatkowski, Sayak Bhattacharya, Daniel Garman, Noah Weisleder, Robert J. Bloch

	The Journal of Physiology. 2022;

	[Pubmed] [Google Scholar] [DOI]

4	Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation

	Yan Xie, Ying-hui Li, Kai Chen, Chun-yan Zhu, Jia-ying Bai, Feng Xiao, Song Tan, Li Zeng

	Frontiers in Neurology. 2022; 13

	[Pubmed] [Google Scholar] [DOI]

5	Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia

	Norah Alharbi, Rawan Matar, Edward Cupler, Hindi Al-Hindi, Hatem Murad, Iftteah Alhomud, Dorota Monies, Ali Alshehri, Mossaed Alyahya, Brian Meyer, Saeed Bohlega

	Frontiers in Neuroscience. 2022; 16

	[Pubmed] [Google Scholar] [DOI]

6	Elevated Ca2+ at the triad junction underlies dysregulation of Ca2+ signaling in dysferlin-null skeletal muscle

	Valeriy Lukyanenko, Joaquin Muriel, Daniel Garman, Leonid Breydo, Robert J. Bloch

	Frontiers in Physiology. 2022; 13

	[Pubmed] [Google Scholar] [DOI]

7	A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B

	Patrizia Spadafora, Antonio Qualtieri, Francesca Cavalcanti, Gemma Di Palma, Olivier Gallo, Selene De Benedittis, Annamaria Cerantonio, Luigi Citrigno

	International Journal of Molecular Sciences. 2022; 23(16): 8932

	[Pubmed] [Google Scholar] [DOI]

8	Causative variants linked with limb girdle muscular dystrophy in an Iranian population: 6 novel variants

	Hamidreza Mianesaz, Safoura Ghalamkari, Mansoor Salehi, Mahdiyeh Behnam, Majid Hosseinzadeh, Keivan Basiri, Majid Ghasemi, Maryam Sedghi, Behnaz Ansari

	Molecular Genetics & Genomic Medicine. 2022;

	[Pubmed] [Google Scholar] [DOI]

9	A novel dysferlin gene mutation in a Filipino male with Miyoshi myopathy

	Karen Joy Adiao, Mario B. Prado, Mina Astejada

	Clinical Neurology and Neurosurgery. 2021; 201: 106433

	[Pubmed] [Google Scholar] [DOI]

10	Myositis mimics

	Sujata Ganguly, Rudrarpan Chatterjee, Abhishek Zanwar, Latika Gupta

	Indian Journal of Rheumatology. 2021; 16(4): 427

	[Pubmed] [Google Scholar] [DOI]

11	Subclinical Cardiomyopathy in Miyoshi Myopathy Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging

	Sarah Ming Li Tan, Ching Ching Ong, Kong Bing Tan, Hui-Lin Chin, Prakash R Paliwal, Kay Wei Ping Ng, Weiqin Lin

	International Heart Journal. 2021; 62(1): 186

	[Pubmed] [Google Scholar] [DOI]

12	Prospects for the Etiotropic Treatment of Dysferlinopathy

	Alisa V. Ivanova, Svetlana A. Smirnikhina, Alexander V. Lavrov

	Annals of the Russian academy of medical sciences. 2021; 76(3): 307

	[Pubmed] [Google Scholar] [DOI]

13	Deep phenotyping of an international series of patients with late-onset dysferlinopathy

	Gorka Fernández-Eulate, Giorgia Querin, Ursula Moore, Anthony Behin, Marion Masingue, Guillaume Bassez, Sarah Leonard-Louis, Pascal Laforêt, Thierry Maisonobe, Philippe-Edouard Merle, Marco Spinazzi, Guilhem Solé, Thierry Kuntzer, Anne-Laure Bedat-Millet, Emmanuelle Salort-Campana, Shahram Attarian, Yann Péréon, Leonard Feasson, Julie Graveleau, Aleksandra Nadaj-Pakleza, France Leturcq, Svetlana Gorokhova, Martin Krahn, Bruno Eymard, Volker Straub, Teresinha Evangelista, Tanya Stojkovic

	European Journal of Neurology. 2021; 28(6): 2092

	[Pubmed] [Google Scholar] [DOI]

14	Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent

	Samya Chakravorty, Babi Ramesh Reddy Nallamilli, Satish Vasant Khadilkar, Madhu Bala Singla, Ashish Bhutada, Rashna Dastur, Pradnya Satish Gaitonde, Laura E Rufibach, Logan Gloster, Madhuri Hegde

	Frontiers in Neurology. 2020; 11

	[Pubmed] [Google Scholar] [DOI]

15	Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation

	Gabriela Fernández, Guisselle Arias-Bravo, Jorge A. Bevilacqua, Mario Castillo-Ruiz, Pablo Caviedes, Juan C. Sáez, Luis A. Cea

	Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020; 1866(8): 165800

	[Pubmed] [Google Scholar] [DOI]

16	Functions of Vertebrate Ferlins

	Anna V. Bulankina, Sven Thoms

	Cells. 2020; 9(3): 534

	[Pubmed] [Google Scholar] [DOI]

17	Early pathological signs in young dysf mice are improved by halofuginone

	Hila Barzilai-Tutsch, Olga Genin, Mark Pines, Orna Halevy

	Neuromuscular Disorders. 2020; 30(6): 472

	[Pubmed] [Google Scholar] [DOI]

18	The effects of concentric and eccentric training in murine models of dysferlin-associated muscular dystrophy

	Morium Begam, Renuka Roche, Joshua J. Hass, Chantel A. Basel, Jacob M. Blackmer, Jasmine T. Konja, Amber L. Samojedny, Alyssa F. Collier, Sujay S. Galen, Joseph A. Roche

	Muscle & Nerve. 2020; 62(3): 393

	[Pubmed] [Google Scholar] [DOI]

19	Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B

	Stephanie L. Sellers,Nadia Milad,Zoe White,Chris Pascoe,Rayleigh Chan,Geoffrey W. Payne,Chun Seow,Fabio Rossi,Michael A. Seidman,Pascal Bernatchez

	Journal of Lipid Research. 2018; 59(2): 261

	[Pubmed] [Google Scholar] [DOI]

20	Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy

	Nirupa J. Patel,Kenneth W. Van Dyke,Luis R. Espinoza

	The American Journal of the Medical Sciences. 2017; 353(5): 484

	[Pubmed] [Google Scholar] [DOI]

21	Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies

	Ana M. Cárdenas,Arlek M. González-Jamett,Luis A. Cea,Jorge A. Bevilacqua,Pablo Caviedes

	Experimental Neurology. 2016; 283: 246

	[Pubmed] [Google Scholar] [DOI]

22	Respiratory and cardiac function in japanese patients with dysferlinopathy

	Atsuko Nishikawa,Madoka Mori-Yoshimura,Kazuhiko Segawa,Yukiko K. Hayashi,Toshiaki Takahashi,Yuko Saito,Ikuya Nonaka,Martin Krahn,Nicolas Levy,Jun Shimizu,Jun Mitsui,En Kimura,Jun Goto,Naohiro Yonemoto,Masashi Aoki,Ichizo Nishino,Yasushi Oya,Miho Murata

	Muscle & Nerve. 2016; 53(3): 394

	[Pubmed] [Google Scholar] [DOI]

23	Progress and challenges in diagnosis of dysferlinopathy

	Marina Fanin,Corrado Angelini

	Muscle & Nerve. 2016; 54(5): 821

	[Pubmed] [Google Scholar] [DOI]

24	The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes

	Luis A. Cea,Jorge A. Bevilacqua,Christian Arriagada,Ana María Cárdenas,Anne Bigot,Vincent Mouly,Juan C. Sáez,Pablo Caviedes

	BMC Cell Biology. 2016; 17(S1)

	[Pubmed] [Google Scholar] [DOI]

25	Myofiber Damage Precedes Macrophage Infiltration after in Vivo Injury in Dysferlin-Deficient A/J Mouse Skeletal Muscle

	Joseph A. Roche,Mohan E. Tulapurkar,Amber L. Mueller,Nico van Rooijen,Jeffrey D. Hasday,Richard M. Lovering,Robert J. Bloch

	The American Journal of Pathology. 2015; 185(6): 1686

	[Pubmed] [Google Scholar] [DOI]

26	AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models

	Patricia C. Sondergaard,Danielle A. Griffin,Eric R. Pozsgai,Ryan W. Johnson,William E. Grose,Kristin N. Heller,Kim M. Shontz,Chrystal L. Montgomery,Joseph Liu,Kelly Reed Clark,Zarife Sahenk,Jerry R. Mendell,Louise R. Rodino-Klapac

	Annals of Clinical and Translational Neurology. 2015; 2(3): 256

	[Pubmed] [Google Scholar] [DOI]

27	Diagnostic overview of blood-based dysferlin protein assay for dysferlinopathies

	Arunkanth Ankala,Babi R Nallamilli,Laura E. Rufibach,Esther Hwang,Madhuri R. Hegde

	Muscle & Nerve. 2014; : n/a

	[Pubmed] [Google Scholar] [DOI]

28	Improved immunoblotting methods provide critical insights into phenotypic differences between two murine dysferlinopathy models

	Amber L. Mueller,Patrick F. Desmond,Ru-ching Hsia,Joseph A. Roche

	Muscle & Nerve. 2014; 50(2): 286

	[Pubmed] [Google Scholar] [DOI]

29	Exome sequencing as a second-tier diagnostic approach for clinically suspected dysferlinopathy patients

	Marc Bartoli,Jean-Pierre Desvignes,Jean-Pierre BSc,Levy Nicolas,Krahn Martin

	Muscle & Nerve. 2014; : n/a

	[Pubmed] [Google Scholar] [DOI]

30	Lipid Accumulation in Dysferlin-Deficient Muscles

	Miranda D. Grounds,Jessica R. Terrill,Hannah G. Radley-Crabb,Terry Robertson,John Papadimitriou,Simone Spuler,Tea Shavlakadze

	The American Journal of Pathology. 2014; 184(6): 1668

	[Pubmed] [Google Scholar] [DOI]

31	New developments in exon skipping and splice modulation therapies for neuromuscular diseases

	Aleksander Touznik,Joshua JA Lee,Toshifumi Yokota

	Expert Opinion on Biological Therapy. 2014; 14(6): 809

	[Pubmed] [Google Scholar] [DOI]

32	Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/myoshi myopathy necessitates mutational screen for diagnosis

	Mats I. Nilsson,Marissa L. Laureano,Munim Saeed,Mark A. Tarnopolsky

	Muscle & Nerve. 2013; 47(5): 740

	[Pubmed] [Google Scholar] [DOI]

33	Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/myoshi myopathy necessitates mutational screen for diagnosis

	Nilsson, M.I. and Laureano, M.L. and Saeed, M. and Tarnopolsky, M.A.

	Muscle and Nerve. 2013; 47(5): 740-747

	[Pubmed] [Google Scholar]

34	Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone

	Halevy, O. and Genin, O. and Barzilai-Tutsch, H. and Pima, Y. and Levi, O. and Moshe, I. and Pines, M.

	Histology and Histopathology. 2013; 28(2): 211-226

	[Pubmed] [Google Scholar]

35	A regional panorama of dysferlinopathies [Disferlinopatilerin bÃ¶lgesel panoramasi{dotless

	Diniz, G. and EryaÅŸar, G. and TÃ¼re, S. and AkÃ§ay, A. and OrtaÃ§, R. and TekgÃ¼l, H. and Akhan, G.

	Turk Patoloji Dergisi/Turkish Journal of Pathology. 2012; 28(3): 259-265

	[Pubmed] [Google Scholar]

36	Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies

	Salani, S. and Donadoni, C. and Rizzo, F. and Bresolin, N. and Comi, G.P. and Corti, S.

	Journal of Cellular and Molecular Medicine. 2012; 16(7): 1353-1364

	[Pubmed] [Google Scholar]

37	Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as anin vitromodel and for therapy of muscular dystrophies

	Sabrina Salani,Chiara Donadoni,Federica Rizzo,Nereo Bresolin,Giacomo P. Comi,Stefania Corti

	Journal of Cellular and Molecular Medicine. 2012; 16(7): 1353

	[Pubmed] [Google Scholar] [DOI]

38	Unmasking Potential Intracellular Roles For Dysferlin through Improved Immunolabeling Methods

	Joseph A. Roche,Lisa W. Ru,Andrea M. O’Neill,Wendy G. Resneck,Richard M. Lovering,Robert J. Bloch

	Journal of Histochemistry & Cytochemistry. 2011; 59(11): 964

	[Pubmed] [Google Scholar] [DOI]

39	Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy

	Eduard Gallardo,Noemi de Luna,Jordi Diaz-Manera,Ricardo Rojas-García,Lidia Gonzalez-Quereda,Bàrbara Flix,Antoine de Morrée,Silvère van der Maarel,Isabel Illa,Markus Schuelke

	PLoS ONE. 2011; 6(12): e29061

	[Pubmed] [Google Scholar] [DOI]

40	UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene

	Dalil Hamroun, Brad Williams, Nilah Monnier, Laura E. Rufibach, Jon Andoni Urtizberea, Gaelle Blandin, Christophe Beroud, Veronique Labelle, Karine Nguyen, Nicolas Wein

	Human Mutation. 2011; : n/a

	[HTML Full text] [Google Scholar] [DOI]

41	Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy

	Gallardo, E. and de Luna, N. and Diaz-Manera, J. and Rojas-GarcÃa, R. and Gonzalez-Quereda, L. and Flix, B. and de MorrÃ©e, A. and van der Maarel, S. and Illa, I.

	PLoS ONE. 2011; 6(12)

	[Pubmed] [Google Scholar]

42	Unmasking Potential Intracellular Roles For Dysferlin through Improved Immunolabeling Methods

	Roche, J.A. and Ru, L.W. and OæNeill, A.M. and Resneck, W.G. and Lovering, R.M. and Bloch, R.J.

	Journal of Histochemistry and Cytochemistry. 2011; 59(11): 964-975

	[Pubmed] [Google Scholar]

43	Ferlin proteins in myoblast fusion and muscle growth

	Posey Jr., A.D. and Demonbreun, A. and McNally, E.M.

	Current Topics in Developmental Biology. 2011; 96: 203-230

	[Pubmed] [Google Scholar]

44	Dysferlinopathy: Spectrum of pathological changes in skeletal muscle tissue

	Gayathri, N. and Alefia, R. and Nalini, A. and Yasha, T.C. and Anita, M. and Santosh, V. and Shankar, S.K.

	Indian Journal of Pathology and Microbiology. 2011; 54(2): 350-354

	[Pubmed] [Google Scholar]

45	Novel ancestral Dysferlin splicing mutation which migrated from the Iberian peninsula to South America



	Neuromuscular Disorders. 2011; 21(5): 328

	[HTML Full text] [Google Scholar] [DOI]

46	Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations



	European Journal of Human Genetics. 2011;

	[HTML Full text] [Google Scholar] [DOI]

47	Exclusion of Mutations in the Dysferlin Alternative Exons 1 ofDYSF-v1, 5a, and 40a in a Cohort of 26 Patients

	Martin Krahn,Véronique Labelle,Ana Borges,Marc Bartoli,Nicolas Lévy

	Genetic Testing and Molecular Biomarkers. 2010; 14(1): 153

	[Pubmed] [Google Scholar] [DOI]

48	Diversification of muscle types: Recent insights from Drosophila

	Vanessa Tixier,Laetitia Bataillé,Krzysztof Jagla

	Experimental Cell Research. 2010; 316(18): 3019

	[Pubmed] [Google Scholar] [DOI]

49	Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies

	Véronique Bolduc,Gareth Marlow,Kym M. Boycott,Khalil Saleki,Hiroshi Inoue,Johan Kroon,Mitsuo Itakura,Yves Robitaille,Lucie Parent,Frank Baas,Kuniko Mizuta,Nobuyuki Kamata,Isabelle Richard,Wim H.J.P. Linssen,Ibrahim Mahjneh,Marianne de Visser,Rumaisa Bashir,Bernard Brais

	The American Journal of Human Genetics. 2010; 86(2): 213

	[Pubmed] [Google Scholar] [DOI]

50	Diversification of muscle types: Recent insights from Drosophila

	Tixier, V. and BataillÃ©, L. and Jagla, K.

	Experimental Cell Research. 2010; 316(18): 3019-3027

	[Pubmed] [Google Scholar]

51	Autosomal recessive limb-girdle muscular dystrophy [Distrofias musculares de cinturas autosÃ³micas recesivas]

	HernÃ¡ndez-Caballero, M.E. and Miranda-Duarte, A. and Escobar-Cedillo, R.E. and Villegas-CastrejÃ³n, H.

	Revista de Neurologia. 2010; 51(8): 489-496

	[Pubmed] [Google Scholar]

52	Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies

	Bolduc, V., Marlow, G., Boycott, K.M., Saleki, K., Inoue, H., Kroon, J., Itakura, M., Brais, B.

	American Journal of Human Genetics. 2010; 86(2): 213-221

	[Pubmed] [Google Scholar]

53	Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice

	Elisabeth R. Barton, Bing Jing Wang, Becky K. Brisson, H. Lee Sweeney

	Muscle & Nerve. 2010; 42(1): 22

	[HTML Full text] [Google Scholar] [DOI]

54	Exclusion of mutations in the dysferlin alternative exons 1 of DYSF-v1, 5a, and 40a in a cohort of 26 patients

	Krahn, M., Labelle, V., Borges, A., Bartoli, M., Lévy, N.

	Genetic Testing and Molecular Biomarkers. 2010; 14(1): 153-154

	[Pubmed] [Google Scholar]

55	Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping

	Anthony Behin, Gillian Butler-Browne, Vincent Mouly, Martin Krahn, Nicolas Wein, AurÃ©lie Avril, Marc Bartoli, Cyriaque Beley, Soraya Chaouch, Pascal Laforet

	Human Mutation. 2010; 31(2): 136-142

	[Pubmed] [Google Scholar] [DOI]

56	Clinical and pathological analysis of limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis

	Li, N. and Liu, Y.-L. and Li, Q.-X. and Yuan, J.-H. and Zhao, Z. and Shen, H.-R. and Hu, J.

	Chinese Journal of Neurology. 2009; 42(9): 596-599

	[Pubmed] [Google Scholar]

Online since 20^th March '04

Published by Wolters Kluwer - Medknow